Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LM-061 / LaNova Medicines Limited
NCT04882176: A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours	Terminated	1/2	18	RoW	LM-061, Kinase inhibitor	LaNova Medicines Limited	Advanced Tumours	02/23	07/23
NCT04737122: Study of LM-061 in Subjects in Advanced Tumors	Terminated	1	18	RoW	LM-061, Kinase inhibitor, Toripalimab	LaNova Medicines Limited	Advanced Tumours	07/22	12/22